Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
2011
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management
2008
Targeting hypoxia in cancer therapy
2011 Standout
Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
2013
The impact of chromosomal microarray on clinical management: a retrospective analysis
2014
Income Differences in Persons Seeking Outpatient Treatment for Mental Disorders
2000
Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice
2010
Epigenomic Annotation of Enhancers Predicts Transcriptional Regulators of Human Neural Crest
2012
Identification of microdeletions in candidate genes for cleft lip and/or palate
2009
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Molecular mechanisms in signal transduction at the membrane
2010
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Network medicine: a network-based approach to human disease
2010 Standout
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
2010
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
2007
Cleft lip and palate: understanding genetic and environmental influences
2011 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor
2011 StandoutNatureNobel
Target cell movement in tumor and cardiovascular diseases based on the epithelial–mesenchymal transition concept
2011
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Insights into genotype–phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3
2010
The “All of Us” Research Program
2019 Standout
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
2012
Prediction of C. elegans Longevity Genes by Human and Worm Longevity Networks
2012 StandoutNobel
The genetics of isolated orofacial clefts: from genotypes to subphenotypes
2009
Genetic Misdiagnoses and the Potential for Health Disparities
2016
Inflammation and cancer: back to Virchow?
2001 Standout
EMT: 2016
2016 Standout
Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development
2012
Hyperactive Ras in developmental disorders and cancer
2007
GEFs and GAPs: Critical Elements in the Control of Small G Proteins
2007
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
The basics of epithelial-mesenchymal transition
2009 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study
2003
The TNF and TNF Receptor Superfamilies
2001 Standout
Increased susceptibility of HIF-1α heterozygous-null mice to cardiovascular malformations associated with maternal diabetes
2013 StandoutNobel
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: A study from the Pediatric Cardiomyopathy Registry
2012
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
2009
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2018
Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy
2012
Anti-Cytokine Therapy for Rheumatoid Arthritis
2000
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
2012 StandoutNobel
TNF-R1 Signaling: A Beautiful Pathway
2002 StandoutScience
Vulnerability of the Developing Heart to Oxygen Deprivation as a Cause of Congenital Heart Defects
2014
How should hypertrophic cardiomyopathy be classified?
2009
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
2013 StandoutNobel
Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys
2004 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Multiple Mutations in Genetic Cardiovascular Disease
2009
Cancer Genome Landscapes
2013 StandoutScience
The role of hypoxia‐inducible factors in carotid body (patho) physiology
2018 StandoutNobel
Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF‐2 pathway
2015 StandoutNobel
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Short Communication: The Cardiac Myosin Binding Protein C Arg502Trp Mutation
2010
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-α (Tnf), Does Not Impair Lymphoid Development
2006 StandoutNobel
Genetic Biomarkers in Hypertrophic Cardiomyopathy
2013
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Works of Amy E. Roberts being referenced
EFFICACY AND TOLERABILITY OF WEEKLY SUBCUTANEOUS INJECTIONS OF THE FULLY HUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID ARTHRITIS-RESULTS OF A PHASE I STUDY
1998
Chromosomal microarray testing influences medical management
2011
The cardiofaciocutaneous syndrome
2006
TFAP2A Mutations Result in Branchio-Oculo-Facial Syndrome
2008
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
2006
Genotype differences in cognitive functioning in Noonan syndrome
2008
Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults
2008
Cardio-Facio-Cutaneous Syndrome: Clinical Features, Diagnosis, and Management Guidelines
2014
Socioeconomic status, ethnicity, psychological distress, and readiness to utilize a mental health facility
1990
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development
2012
Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines
2010